Filtered By:
Source: Circulation
Condition: Atrial Fibrillation
This page shows you your search results in order of date. This is page number 11.
Order by Relevance | Date
Total 235 results found since Jan 2013.
Letter by Asinger et al Regarding Articles, "Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke" and "Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated?: The CHA2DS2-VASc 1 Conundrum: Decision Making at the Lower End of the Risk Spectrum".
PMID: 27799260 [PubMed - in process]
Source: Circulation - October 31, 2016 Category: Cardiology Authors: Asinger RW, Shroff GR, Herzog CA Tags: Circulation Source Type: research
Response by Halperin and Savino to Letter Regarding Article, "Should Patients with Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? The CHA2DS2-VASc 1 Conundrum: Decision Making at the Lower End of the Risk Spectrum".
PMID: 27799262 [PubMed - in process]
Source: Circulation - October 31, 2016 Category: Cardiology Authors: Halperin JL, Savino JA Tags: Circulation Source Type: research
Response by Nielsen and Lip to Letter Regarding Article, "Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke".
PMID: 27799261 [PubMed - in process]
Source: Circulation - October 31, 2016 Category: Cardiology Authors: Nielsen PB, Lip GY Tags: Circulation Source Type: research
Wide Variation in Reported Rates of Stroke Across Cohorts of Patients with Atrial Fibrillation.
CONCLUSIONS: -There is substantial variation across cohorts in overall stroke rates and rates corresponding to CHA2DS2-VASc point scores. These variations can affect the point score threshold for recommending OAC in AF. The majority of cohorts did not observe stroke rates that would indicate a clear expected net clinical benefit for anticoagulating AF patients with CHA2DS2-VASc scores of 1 or 2.
PMID: 27799272 [PubMed - as supplied by publisher]
Source: Circulation - October 30, 2016 Category: Cardiology Authors: Quinn GR, Severdija ON, Chang Y, Singer DE Tags: Circulation Source Type: research
Clinical Outcomes in 3343 Children and Adults with Rheumatic Heart Disease from 14 Low and Middle Income Countries: 2-Year Follow-up of the Global Rheumatic Heart Disease Registry (the REMEDY study).
CONCLUSIONS: -Patients with clinical RHD have high mortality and morbidity despite being young; those from low and lower-middle income countries had a poorer prognosis associated with advanced disease and low education. Programs focused on early detection and treatment of clinical RHD are required to improve outcomes.
PMID: 27702773 [PubMed - as supplied by publisher]
Source: Circulation - October 3, 2016 Category: Cardiology Authors: Zühlke L, Karthikeyan G, Engel ME, Rangarajan S, Mackie P, Cupido B, Mauff K, Islam S, Daniels R, Francis V, Ogendo S, Gitura B, Mondo C, Okello E, Lwabi P, Al-Kebsi MM, Hugo-Hamman C, Sheta SS, Haileamlak A, Daniel W, Goshu DY, Abdissa SG, Desta AG, Sha Tags: Circulation Source Type: research
Response by Chao et al to Letters Regarding Article, "Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage".
PMID: 27619720 [PubMed - in process]
Source: Circulation - September 12, 2016 Category: Cardiology Authors: Chao TF, Liu CJ, Liao JN, Wang KL, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Chung FP, Chen TJ, Lip GY, Chen SA Tags: Circulation Source Type: research
Letter by Yang et al Regarding Article, "Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage".
PMID: 27619719 [PubMed - in process]
Source: Circulation - September 12, 2016 Category: Cardiology Authors: Yang X, An R, Xu Y Tags: Circulation Source Type: research
Letter by Chan and Siu Regarding Article, "Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage".
PMID: 27619718 [PubMed - in process]
Source: Circulation - September 12, 2016 Category: Cardiology Authors: Chan PH, Siu CW Tags: Circulation Source Type: research
Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation.
CONCLUSIONS: -The biomarker-based ABC-stroke score was well calibrated and consistently performed better than both the CHA2DS2VASc and ATRIA stroke scores. The ABC score should be considered an improved decision support tool in the care of patients with AF. Clinical Trial Registration-ClinicalTrials.gov identifier: ARISTOTLE; NCT00412984, ClinicalTrials.gov identifier: RE-LY; NCT00262600.
PMID: 27569438 [PubMed - as supplied by publisher]
Source: Circulation - August 27, 2016 Category: Cardiology Authors: Oldgren J, Hijazi Z, Lindbäck J, Alexander JH, Connolly SJ, Eikelboom JW, Ezekowitz MD, Granger CB, Hylek EM, Lopes RD, Siegbahn A, Yusuf S, Wallentin L Tags: Circulation Source Type: research
Trajectories of Cardiovascular Risk Factors and Incidence of Atrial Fibrillation Over a 25-Year Follow-Up: The ARIC Study (Atherosclerosis Risk in Communities).
CONCLUSIONS: AF patients have increased prevalence of CVRF many years before disease diagnosis. This analysis identified diverse trajectories in the prevalence of these risk factors, highlighting their different roles in AF pathogenesis.
PMID: 27550968 [PubMed - in process]
Source: Circulation - August 22, 2016 Category: Cardiology Authors: Norby FL, Soliman EZ, Chen LY, Bengtson LG, Loehr LR, Agarwal SK, Alonso A Tags: Circulation Source Type: research
Comparison of Dabigatran versus Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: The RE-LY Trial.
CONCLUSIONS: -The presence of any VHD did not influence the comparison of dabigatran with warfarin. Clinical Trial Registration-URL: http://clinicaltrials.gov. Unique Identifier: NCT00262600.
PMID: 27496855 [PubMed - as supplied by publisher]
Source: Circulation - August 4, 2016 Category: Cardiology Authors: Ezekowitz MD, Nagarakanti R, Noack H, Brueckmann M, Litherland C, Jacobs M, Clemens A, Reilly PA, Connolly SJ, Yusuf S, Wallentin L Tags: Circulation Source Type: research
Response by Piccini et al to Letters Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".
PMID: 27400902 [PubMed - in process]
Source: Circulation - July 11, 2016 Category: Cardiology Authors: Piccini JP, Hellkamp AS, Washam JB, Becker RC, Breithardt G, Berkowitz SD, Halperin JL, Hankey GJ, Hacke W, Mahaffey KW, Nessel CC, Singer DE, Fox KA, Patel MR Tags: Circulation Source Type: research
Letter by Imprialos et al Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".
PMID: 27400901 [PubMed - in process]
Source: Circulation - July 11, 2016 Category: Cardiology Authors: Imprialos K, Boutari C, Stavropoulos K Tags: Circulation Source Type: research
Letter by Bouatou et al Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".
PMID: 27400900 [PubMed - in process]
Source: Circulation - July 11, 2016 Category: Cardiology Authors: Bouatou Y, El Biali M, Samer CF Tags: Circulation Source Type: research
On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF.
CONCLUSIONS: Among patients with on-treatment WRF, rivaroxaban was associated with lower rates of stroke and systemic embolism compared with warfarin, without an increase in the composite bleeding end point.
CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00403767.
PMID: 27358435 [PubMed - in process]
Source: Circulation - July 2, 2016 Category: Cardiology Authors: Fordyce CB, Hellkamp AS, Lokhnygina Y, Lindner SM, Piccini JP, Becker RC, Berkowitz SD, Breithardt G, Fox KA, Mahaffey KW, Nessel CC, Singer DE, Patel MR, ROCKET AF Steering Committee and Investigators Tags: Circulation Source Type: research
